The Executive team has a proven track record in moving rapidly from scientific concepts to clinical development.

The achievement of our goals is largely driven by the competences and the skills of the ASIT biotech employees. Expertise, professional experience and commitment are at the heart of our business. It is through the dedicated work of ASIT biotech's teams that breakthrough allergy immunotherapy drugs are invented and further developed.

Executive management team

ThierryLegon

Thierry Legon
CEO

Ir. Agronomy, MBA, Thierry Legon was in charge for ten years of the management of the intellectual property and technology transfer of the University of Brussels (ULB). Thierry was also a board member of Euroscreen (a drug discovery biotech company) for eight years.

In May 1997, Thierry founded ASIT biotech as a spin-off company of the ULB. As Chief Executive Officer (CEO) since 2000, Thierry has successfully designed consecutive business plans, raised the required funds and is leading the team to achieve the goals of the company.

EverardVanDerStraten

Everard van der Straten
CFO

Everard van der Straten holds a master from Solvay Business School. After a short career as auditor at Arthur and Anderson & Co, Everard was managing director of Metallo-Chimique Group and afterwards Board Member of the Metallum Group until end 2008. Currently, Everard is as well Business Angel.

FrançoisMeurgey

François Meurgey
Marketing & Commercialisation

As managing Partner of Oukelos, François is working as independent consultant in pharmaceutical product strategic marketing. He spent more than twenty-five years in the biopharmaceutical industry, both in Europe and the United States, and holding both operational and higher management functions like Director of Global Marketing for Prozac® at Eli Lilly, Senior Director of Asia-Pacific Marketing at Merck & Co. and Vice-President of Global Marketing at UCB. François graduated from Reims Management School, received a master degree in International Relations from University of Paris-Sorbonne and holds an MBA from the Stern School of Business, New York University.

Larger management team

AlbertVicaire

Albert Vicaire
Secretary of the company

Dipl. Eng., MBA, Albert Vicaire uses his twenty-year experience in human resources to manage ASIT biotech administration. His pragmatic problem solving approach helps the scientific team to focus on the development of the ASIT+TM products.

SabinePirotton

Sabine Pirotton
Senior Clinical Project Manager

PhD in Biochemistry, Sabine Pirotton joined ASIT biotech in 2005, after twenty years as senior scientist at the University of Brussels and the University of Namur. She is co-inventor of the major ASIT biotech patents. Since 2007, Sabine is in charge of the design, the submission and the management of the clinical trials of ASIT biotech.

GaelPlacier

Gaël Placier
Senior Product Development Manager

PhD in Biochemistry, Gaël Placier has twenty years basic and applied research experience. Before joining ASIT biotech, Gael hold a senior scientist position in Industrielle Genetik Institute of Stuttgart (Germany). Gaël has developed and optimized the ASIT+TM technology platform. Gaël is one of the inventors of the ASIT biotech patents.